CN1181257A - Prescription of anti-cancer agent belonging to anti-cancer Chinese herbs - Google Patents
Prescription of anti-cancer agent belonging to anti-cancer Chinese herbs Download PDFInfo
- Publication number
- CN1181257A CN1181257A CN 96119535 CN96119535A CN1181257A CN 1181257 A CN1181257 A CN 1181257A CN 96119535 CN96119535 CN 96119535 CN 96119535 A CN96119535 A CN 96119535A CN 1181257 A CN1181257 A CN 1181257A
- Authority
- CN
- China
- Prior art keywords
- cancer
- chinese herbal
- herbal medicine
- prescription
- anticarcinogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese anticancer medicine for curing liver concer, stomach cancer, lung cancer, throat cancer and breast cancer is prepared from 8 Chinese-medicinal materials such as red-white flower alfalfa, viscum coloratum, wild walnut twig or bark, madder, anemarrhena rhizome, etc.
Description
The invention provides a kind of Chinese herbal medicine medicament, specifically a kind of Chinese herbal medicine three that is used for the treatment of cancers such as hepatocarcinoma, gastric cancer, pulmonary carcinoma, breast carcinoma or laryngeal carcinoma closes the prescription of five anticarcinogen.
Cancer is the malignant tumor that is formed by epithelial cell, medically is being still to fail one of pertinacious disease of effectively curing.At present for treatment for cancer, mainly according to the character of cancer, various Therapeutic Method are adopted at position and have or not transfer, comprise operation, chemotherapy, radiation, medicine etc.In medical literature, have report to can be used for the Chinese herbal medicine of treatment of cancer, also have folklore relevant prevent and treat carninomatosis single, test and folk prescription.
The purpose of this invention is to provide the prescription that a kind of anticancer herbal drug three for the treatment of cancer closes five anticarcinogen, the made Chinese herbal medicine of this prescription has higher curative effect to cancers such as hepatocarcinoma, gastric cancer, pulmonary carcinoma, breast carcinoma or laryngeal carcinoma.
Of the present invention three prescriptions that close five anticarcinogen be adopted 3 Chinese herbal medicine hosts and five Chinese herbal medicine adjuvant totally 8 medical herbs form, wherein 3 Chinese herbal medicine host is redly to spend Herba Medicaginis in vain and (have another name called red butch clover, red T.repens or red Holland Astragalus sinicus), little Mongolian oak wood and Semen Caryae Cathayensis branch and/or skin, 5 Chinese herbal medicine adjuvant are Radix Rubiaes, the Rhizoma Anemarrhenae, Fructus Jujubae, Hedyotidis Diffusae and Herba Scutellariae Barbatae.The additional proportion of each composition is that 3 hosts are respectively by 3～6 in the prescription, and adjuvant is respectively pressed 2～5 weight proportion adding, 3 major pharmaceuticals in the above-mentioned anticarcinogen are red spends Herba Medicaginis in vain, little Mongolian oak wood and Semen Caryae Cathayensis branch and/or skin all have the anticancer growth, kill and wound cancerous cell, antitoxin bacterium effect, and 3 kinds of medicaments use simultaneously can more effectively bring into play smelting treatment effect, and Radix Rubiae is that the clear crystal material that contains 7 kinds of ring-type peptides and be called as RA-7 all has certain antitumaous effect in 5 adjuvant, contain zhimusaponin unit in the Rhizoma Anemarrhenae, be a kind of sodium pump inhibitor, can not only improve the interior-heat caused by deficiency of YIN disease, and can to a certain degree suppress liver cancer cell growth; Fructus Jujubae also is considered to have the material of certain active anticancer; Hedyotidis Diffusae and Herba Scutellariae Barbatae all have heat-clearing and toxic substances removing, the effect of raise immunity.These 5 assistant medicaments are joined in the major pharmaceutical, can play the increase curative effect at therapeutic process, promote and improve the effect of patient's autoimmune function, cooperate major pharmaceutical to promote macrophage, engulf cancerous cell and inverse cancer cell, make of the present invention three to close five anticarcinogen and have clinical effectiveness preferably.
Utilize of the present invention three to close five anticarcinogen prescriptions, press the preparation method of Chinese herbal medicine conventional dose, for example decoct Chinese herbal medicine and swing agent and make the treatment that pill can be used for the cancer patient.This anticarcinogen Chinese herbal medicine all has significant curative effect to cancers such as hepatocarcinoma, gastric cancer, pulmonary carcinoma, breast carcinoma or laryngeal carcinoma through clinical practice result proof, transfers to diseases such as head of pancreas or bone and also has extremely long-pending ground therapeutic effect canceration has taken place late period.
Technology of the present invention is given to illustrate further with facing to use below by example.
Five anticarcinogen decoctions are closed in example 1 preparation three
Take by weighing the red Herba Medicaginis of spending in vain, little Mongolian oak wood and Semen Caryae Cathayensis branch and/or each 40g of skin, Radix Rubiae, the Rhizoma Anemarrhenae, Fructus Jujubae, each 30g of Hedyotidis Diffusae and Herba Scutellariae Barbatae makes the decoction of Second Mate's dose by the fried way of herbal decoction.
Example 2 three closes the clinical practice of five anticarcinogen
Utilize the medicament of example 1 preparation to carry out clinical treatment in the carninomatosis patient, instructions of taking is that one pair of medicine divides sooner or later respectively once for the dose of adult's example 1, take 15 pairs continuously, one month is a course of treatment, check (but to the light patient's drug withdrawal of the state of an illness after taking two courses of treatment, can take continuously one month again heavier patient), 15 examples to be suffered from liver cancer patient carry out clinical follow-up observation, its therapeutic outcome is listed in table 1.
Evaluation criterion: cure, lump obviously reduces or disappears, and does not have the sense of swelling and ache, and patient's self-induction does not have any discomfort symptom; Produce effects, lump does not increase or diminishes, and does not have the sense of swelling and ache; Effectively, lump does not increase, and swelling and ache obviously alleviates; Invalid, swelling and ache not have obviously alleviates.
Table 1 three closes the invalid effective produce effects of curative effect case load that five anticarcinogen are used for the treatment of the hepatocarcinoma disease and cures 15 01 10 4
Embodiment 3 three closes the clinical practice of five anticarcinogen
Press example 2 described Therapeutic Method, to suffering from gastric cancer, pulmonary carcinoma, laryngeal carcinoma and breast carcinoma case are carried out clinical treatment, and its therapeutic outcome is listed in table 2.
Table 2 three closes invalid effective produce effects healing gastric cancer 10 0163 pulmonary carcinoma 10 0271 laryngeal carcinoma 10 0262 mammary cancer 1s 50186 of curative effect disease case load that five anticarcinogen are used for the treatment of cancer
For in the above-mentioned clinical effectiveness effectively the case patient continued to take medicine of the present invention 1～2 month, the patient feels that all the disease cure rate that further obtains taking a turn for the better significantly improves.
Claims (3)
1. an anticancer herbal drug three closes the prescription of five anticarcinogen, it is characterized in that being made up of 3 Chinese herbal medicine hosts and 5 Chinese herbal medicine adjuvant, and wherein the host Chinese herbal medicine is the red Herba Medicaginis of spending in vain, little Mongolian oak wood and Semen Caryae Cathayensis branch and/or skin, the adjuvant Chinese herbal medicine is a Radix Rubiae, the Rhizoma Anemarrhenae, Fructus Jujubae, Hedyotidis Diffusae and Herba Scutellariae Barbatae.
2. according to the described prescription of claim 1, the additional proportion that it is characterized in that each composition be 3 hosts respectively by 3～6, and adjuvant respectively adds by 2～5 weight proportion.
3. application that anticancer herbal drug three closes five anticarcinogen is to be used for the treatment of hepatocarcinoma, gastric cancer, pulmonary carcinoma, laryngeal carcinoma and breast carcinoma.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96119535 CN1181257A (en) | 1996-11-06 | 1996-11-06 | Prescription of anti-cancer agent belonging to anti-cancer Chinese herbs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96119535 CN1181257A (en) | 1996-11-06 | 1996-11-06 | Prescription of anti-cancer agent belonging to anti-cancer Chinese herbs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1181257A true CN1181257A (en) | 1998-05-13 |
Family
ID=5125786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96119535 Pending CN1181257A (en) | 1996-11-06 | 1996-11-06 | Prescription of anti-cancer agent belonging to anti-cancer Chinese herbs |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1181257A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100427099C (en) * | 2006-03-02 | 2008-10-22 | 上海交通大学 | Juglans mandshurica maxim pdysaccharide preparation capable of effectively treating brain cancer and its preapring method |
| CN105853618A (en) * | 2016-04-14 | 2016-08-17 | 黑龙江中医药大学 | Traditional Chinese medicine composition with broad-spectrum anti-cancer effect as well as preparation method and application thereof |
-
1996
- 1996-11-06 CN CN 96119535 patent/CN1181257A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100427099C (en) * | 2006-03-02 | 2008-10-22 | 上海交通大学 | Juglans mandshurica maxim pdysaccharide preparation capable of effectively treating brain cancer and its preapring method |
| CN105853618A (en) * | 2016-04-14 | 2016-08-17 | 黑龙江中医药大学 | Traditional Chinese medicine composition with broad-spectrum anti-cancer effect as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014139282A1 (en) | Pharmaceutical compositions for treating cancer of genital system and preparation method therefor | |
| CN102283867B (en) | Traditional Chinese medicine composition for treating cancer | |
| CN103861079B (en) | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors | |
| CN101711848A (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN1048409C (en) | Capsule for protecting liver and eliminating tumor | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN102940808A (en) | Prescription medicine for treating lung cancer and preparation method | |
| CN100386106C (en) | Medicine for treating acne and its preparation | |
| CN100406026C (en) | Medicine for treating chronic gastritis and gastric carcinoma, and its prepn. method | |
| CN101543616A (en) | Traditional Chinese medicine composition for preventing and treating tumor and its preparation method | |
| CN1181257A (en) | Prescription of anti-cancer agent belonging to anti-cancer Chinese herbs | |
| CN103083387A (en) | Congestion-eliminating pain-relieving plaster | |
| CN100427132C (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN1057220C (en) | Compound anticancer Chinese medicine | |
| CN112402565B (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method thereof | |
| CN112402566B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating gonarthromeningitis | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN106511579A (en) | Medicine composition for treating gynecological diseases and the like | |
| CN100560087C (en) | Pharmaceutical composition of treatment malignant tumor and preparation method thereof | |
| CN102205109A (en) | Chinese medicinal composition for treating rheumatism and application thereof | |
| CN106619870A (en) | Composition for treating digestive system neoplasms, and preparation method of composition | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN106237156A (en) | A kind of Chinese medicine composition treating gastric cancer and preparation method thereof | |
| CN1253003A (en) | Compound graceful jassamine preparation | |
| CN105434533A (en) | Traditional Chinese medicine composition for treating liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |